skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: hi group I asked a question on bio tech last Wed - no response as of yet ? - please follow up. The question was do you like the sector/ and what ETFs /top 3 individual stocks do you recommend thanks
Read Answer Asked by Terence on October 19, 2020
Q: Hi group I am up 15% on W ( full position)should I sell before 3 rd quarter results are out at the end of Oct. What are the expected results / do you think the growth continues especially when the Virus concerns are climbing. Is it a hold ,Sell, or buy more on dips. Moderate risk older investor. Thanks for your guidance its much appreciated
Read Answer Asked by Terence on October 19, 2020
Q: Are there any companies i should look into that are in the machine learning and A.I. space. I believe there has been and will be great opurtunity here
Read Answer Asked by Tim on October 19, 2020
Q: Hi there. I hold positions in ABBV, PFE, MRNA, and AMGEN. I am looking for some supplemental help in the healthcare space and considering MDT, WBA, JNJ(on pull back and aware of legal risks).

What would your opinion and/or recommendations be on these companies JNJ/WBA/MDT Do you have one or two alternatives for a dividend conscious investor?

Thank you so much.
Peter
Read Answer Asked by Peter on October 19, 2020
Q: NVDA up 200%, AMD up 180%, TSM up 79% and QCOM up 70% in one year. Can I have your opinion on which would have more legs for continued share rise given current conditions within these companies, etc. Thanks so much. Dam Dan
Read Answer Asked by Danny-boy on October 16, 2020
Q: Can I get your outlook for this company

thank you
Read Answer Asked by Tova on October 16, 2020
Q: On Oct 1, Beam Therapeutics announced an equity offering priced at $23.50/share; over the following days, the share price declined to as low as $22.24, i.e., below the offering price, though not as low as would reflect the dilutive effect of the new shares.

Yet today shares traded as high as $34.38; what, if anything, can we infer from this disconnect? Who would pay so much when new shares can be had at 2/3 the price?
Read Answer Asked by John on October 16, 2020
Q: I am wondering about what stocks in the US you would see as cratering upon the announcement of an effective vaccine for covid. I see a significant vaccine breakthrough happening sometime within the next 6 months (or sooner) albeit with its attendant issues such as who gets it first, distribution, quantities, cost, etc but at least step 1 would be having the vaccine. I mean, just consider the gigantic effort being put into vaccine development. In particular, I'm wondering about buying ZOOM which now has a P/E in the 600 to 700(!) plus range depending on where you look. CNBC lists Zoom's peers among others as TEAM and DOCU which I already have full positions in. These all look wonderful to me now in a heavily covid world, but are they set up for a huge decline upon a significant vaccine announcement? Thank you.
Read Answer Asked by William on October 15, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!